Published: Aug-2022|  Format: PDF | QY Research |  Number of pages: 116 | Code: MBI-3389436

Heart Failure Treatment Market by Products (Drug Treatment, Surgical Treatment), by Applications (Acute Heart Failure, Chronic Heart Failure) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Select a Format




 Buy Now

The Global Heart Failure Treatment Market was valued at USD XXX in 2022 and it is projected to surpass around USD XX by 2030 with a registered CAGR of xxx during the forecast period 2022 to 2030.

Growth factor

Our new latest report titled, global Heart Failure Treatment Market comes up with comprehensive analysis of the industry including emerging trends and current development of the market. The report offers comprehensive insights of the industry with details of market share, size, revenue, growth opportunities, regional insights and major companies. The report provides all necessary and vital information related to the global market to help the buyer, the readers, investors get a complete understanding of the market and invest accordingly to the upcoming challenges and opportunities.

List of Key Players Operating in the Market:

The report provides in-depth research about each player operating in the global Heart Failure Treatment Market along with its worldwide financial position, previous and upcoming business expansion plans, new product launches. The upcoming activities of the key players related to various strategies such as acquisitions, partnerships, mergers and, joint ventures, research and development investments.

  • Pfizer
  • Novartis
  • Merck
  • Sanofi
  • Johnson & Johnson
  • AstraZeneca
  • GlaxoSmithKline
  • Amgen
  • Bayer
  • BMS
  • Cardiorentis
  • Cytokinetics
  • Ono Pharmaceuticals
  • Mylan
  • NCPC
  • Xinhua Group
  • Xudong Haipu Pharmaceutical

Market research report presents an analysis of all the data collected through primary and secondary resources. Our well experienced team of analyst collects all the information from several leading entities press release, government publication sources such as gold standard, silver standard, white papers, articles and websites, corporate filings including financial statements, annual reports, investor presentations, etc.

Our Report offers detailed insights market valuation, volume, share, outlook, production capacity and price analysis for the forecast period 2022-2030. Furthermore, the study also includes market segmentation on the basis of product, application, end-users, supply chain, distribution channel and other segment. Additionally, the study also includes market segmentation based on upstream downstream demand analysis, feedstock, and consumption rate and market share. It employs both primary and secondary methods of data collection to obtain relevant and sustainable information of the market.

This exclusive report includes detailed information about the market related activities such as Partnerships, stake holder position, Sole Traders, which create, develop, and conduct activities for the study and analysis of markets as per the customization and specifications of the client.

Segment Analysis of the Market:

The objective of the report mainly provides an essential overview of the Heart Failure Treatment Market with detailed market segmentation by product, end-users, distribution channel, technology, content, type, application and region. The global market is expected to witness rapid growth during the forecast period. The report provides growth drivers, challenges, restraints of the region. It also offers the fastest growing segment with future scope, advancement emerging trends. The study examines the global scenario of the market by conducting an economy-wide assessment along with a comprehensive study involving product costs, drivers and restrictions, demands, profit analysis, production, distribution, and year-on-year growth rates.

By Type

  • Drug Treatment
  • Surgical Treatment

By Application

  • Acute Heart Failure
  • Chronic Heart Failure

Key Question Answered in this In-depth Market Report 2022-2028:

  • What was the market valued in the past year?
  • What will be the projected size, share and CAGR of the market?
  • What was the market status across the globe?
  • What are the profit margins in global Heart Failure Treatment Market?
  • What are the growth factors boosts the market for the forecast period?
  • Which segment is going to boom in the near future?
  • What are the upcoming trends of the market?
  • Who are the key companies or players of the market?
  • Which is the fastest growing region of the global Heart Failure Treatment Market?

Regional Insights:

The government initiative increasing the development activities of the Heart Failure Treatment Market. On the other hand the major reason behind the growth is the market key players are expanding their operation in this region.

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Exclusive Report Offers:

  1. To study and analyze the global Heart Failure Treatment Market consumption rate by key regions, type and application, historical data from past five years, and for upcoming years.
  2. The global research study look at the market to identify key influencing factors and entry barriers.
  3. To understand the structure of market by identifying and studying its various segments.
  4. To analyze with respect to individual prospects, growth factors, emerging trends, and their contribution to the whole market.
  5. Study focuses on the analysis of key players, to describe and analyze the sales volume, company size, share, value, market competition landscape, SWOT analysis and development plans in the near future.
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Heart Failure Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Drug Treatment
        1.2.3 Surgical Treatment
    1.3 Market by Application
        1.3.1 Global Heart Failure Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Acute Heart Failure
        1.3.3 Chronic Heart Failure
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Heart Failure Treatment Market Perspective (2017-2028)
    2.2 Heart Failure Treatment Growth Trends by Region
        2.2.1 Heart Failure Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Heart Failure Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Heart Failure Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Heart Failure Treatment Market Dynamics
        2.3.1 Heart Failure Treatment Industry Trends
        2.3.2 Heart Failure Treatment Market Drivers
        2.3.3 Heart Failure Treatment Market Challenges
        2.3.4 Heart Failure Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Heart Failure Treatment Players by Revenue
        3.1.1 Global Top Heart Failure Treatment Players by Revenue (2017-2022)
        3.1.2 Global Heart Failure Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Heart Failure Treatment Revenue
    3.4 Global Heart Failure Treatment Market Concentration Ratio
        3.4.1 Global Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Heart Failure Treatment Revenue in 2021
    3.5 Heart Failure Treatment Key Players Head office and Area Served
    3.6 Key Players Heart Failure Treatment Product Solution and Service
    3.7 Date of Enter into Heart Failure Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Heart Failure Treatment Breakdown Data by Type
    4.1 Global Heart Failure Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Heart Failure Treatment Forecasted Market Size by Type (2023-2028)
5 Heart Failure Treatment Breakdown Data by Application
    5.1 Global Heart Failure Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Heart Failure Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Heart Failure Treatment Market Size (2017-2028)
    6.2 North America Heart Failure Treatment Market Size by Type
        6.2.1 North America Heart Failure Treatment Market Size by Type (2017-2022)
        6.2.2 North America Heart Failure Treatment Market Size by Type (2023-2028)
        6.2.3 North America Heart Failure Treatment Market Share by Type (2017-2028)
    6.3 North America Heart Failure Treatment Market Size by Application
        6.3.1 North America Heart Failure Treatment Market Size by Application (2017-2022)
        6.3.2 North America Heart Failure Treatment Market Size by Application (2023-2028)
        6.3.3 North America Heart Failure Treatment Market Share by Application (2017-2028)
    6.4 North America Heart Failure Treatment Market Size by Country
        6.4.1 North America Heart Failure Treatment Market Size by Country (2017-2022)
        6.4.2 North America Heart Failure Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Heart Failure Treatment Market Size (2017-2028)
    7.2 Europe Heart Failure Treatment Market Size by Type
        7.2.1 Europe Heart Failure Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Heart Failure Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Heart Failure Treatment Market Share by Type (2017-2028)
    7.3 Europe Heart Failure Treatment Market Size by Application
        7.3.1 Europe Heart Failure Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Heart Failure Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Heart Failure Treatment Market Share by Application (2017-2028)
    7.4 Europe Heart Failure Treatment Market Size by Country
        7.4.1 Europe Heart Failure Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Heart Failure Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Heart Failure Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Heart Failure Treatment Market Size by Type
        8.2.1 Asia-Pacific Heart Failure Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Heart Failure Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Heart Failure Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Heart Failure Treatment Market Size by Application
        8.3.1 Asia-Pacific Heart Failure Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Heart Failure Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Heart Failure Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Heart Failure Treatment Market Size by Region
        8.4.1 Asia-Pacific Heart Failure Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Heart Failure Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Heart Failure Treatment Market Size (2017-2028)
    9.2 Latin America Heart Failure Treatment Market Size by Type
        9.2.1 Latin America Heart Failure Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Heart Failure Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Heart Failure Treatment Market Share by Type (2017-2028)
    9.3 Latin America Heart Failure Treatment Market Size by Application
        9.3.1 Latin America Heart Failure Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Heart Failure Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Heart Failure Treatment Market Share by Application (2017-2028)
    9.4 Latin America Heart Failure Treatment Market Size by Country
        9.4.1 Latin America Heart Failure Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Heart Failure Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Heart Failure Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Heart Failure Treatment Market Size by Type
        10.2.1 Middle East & Africa Heart Failure Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Heart Failure Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Heart Failure Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Heart Failure Treatment Market Size by Application
        10.3.1 Middle East & Africa Heart Failure Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Heart Failure Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Heart Failure Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Heart Failure Treatment Market Size by Country
        10.4.1 Middle East & Africa Heart Failure Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Heart Failure Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Heart Failure Treatment Introduction
        11.1.4 Pfizer Revenue in Heart Failure Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Heart Failure Treatment Introduction
        11.2.4 Novartis Revenue in Heart Failure Treatment Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck Heart Failure Treatment Introduction
        11.3.4 Merck Revenue in Heart Failure Treatment Business (2017-2022)
        11.3.5 Merck Recent Developments
    11.4 Sanofi
        11.4.1 Sanofi Company Details
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Heart Failure Treatment Introduction
        11.4.4 Sanofi Revenue in Heart Failure Treatment Business (2017-2022)
        11.4.5 Sanofi Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Heart Failure Treatment Introduction
        11.5.4 Johnson & Johnson Revenue in Heart Failure Treatment Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Heart Failure Treatment Introduction
        11.6.4 AstraZeneca Revenue in Heart Failure Treatment Business (2017-2022)
        11.6.5 AstraZeneca Recent Developments
    11.7 GlaxoSmithKline
        11.7.1 GlaxoSmithKline Company Details
        11.7.2 GlaxoSmithKline Business Overview
        11.7.3 GlaxoSmithKline Heart Failure Treatment Introduction
        11.7.4 GlaxoSmithKline Revenue in Heart Failure Treatment Business (2017-2022)
        11.7.5 GlaxoSmithKline Recent Developments
    11.8 Amgen
        11.8.1 Amgen Company Details
        11.8.2 Amgen Business Overview
        11.8.3 Amgen Heart Failure Treatment Introduction
        11.8.4 Amgen Revenue in Heart Failure Treatment Business (2017-2022)
        11.8.5 Amgen Recent Developments
    11.9 Bayer
        11.9.1 Bayer Company Details
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Heart Failure Treatment Introduction
        11.9.4 Bayer Revenue in Heart Failure Treatment Business (2017-2022)
        11.9.5 Bayer Recent Developments
    11.10 BMS
        11.10.1 BMS Company Details
        11.10.2 BMS Business Overview
        11.10.3 BMS Heart Failure Treatment Introduction
        11.10.4 BMS Revenue in Heart Failure Treatment Business (2017-2022)
        11.10.5 BMS Recent Developments
    11.11 Cardiorentis
        11.11.1 Cardiorentis Company Details
        11.11.2 Cardiorentis Business Overview
        11.11.3 Cardiorentis Heart Failure Treatment Introduction
        11.11.4 Cardiorentis Revenue in Heart Failure Treatment Business (2017-2022)
        11.11.5 Cardiorentis Recent Developments
    11.12 Cytokinetics
        11.12.1 Cytokinetics Company Details
        11.12.2 Cytokinetics Business Overview
        11.12.3 Cytokinetics Heart Failure Treatment Introduction
        11.12.4 Cytokinetics Revenue in Heart Failure Treatment Business (2017-2022)
        11.12.5 Cytokinetics Recent Developments
    11.13 Ono Pharmaceuticals
        11.13.1 Ono Pharmaceuticals Company Details
        11.13.2 Ono Pharmaceuticals Business Overview
        11.13.3 Ono Pharmaceuticals Heart Failure Treatment Introduction
        11.13.4 Ono Pharmaceuticals Revenue in Heart Failure Treatment Business (2017-2022)
        11.13.5 Ono Pharmaceuticals Recent Developments
    11.14 Mylan
        11.14.1 Mylan Company Details
        11.14.2 Mylan Business Overview
        11.14.3 Mylan Heart Failure Treatment Introduction
        11.14.4 Mylan Revenue in Heart Failure Treatment Business (2017-2022)
        11.14.5 Mylan Recent Developments
    11.15 NCPC
        11.15.1 NCPC Company Details
        11.15.2 NCPC Business Overview
        11.15.3 NCPC Heart Failure Treatment Introduction
        11.15.4 NCPC Revenue in Heart Failure Treatment Business (2017-2022)
        11.15.5 NCPC Recent Developments
    11.16 Xinhua Group
        11.16.1 Xinhua Group Company Details
        11.16.2 Xinhua Group Business Overview
        11.16.3 Xinhua Group Heart Failure Treatment Introduction
        11.16.4 Xinhua Group Revenue in Heart Failure Treatment Business (2017-2022)
        11.16.5 Xinhua Group Recent Developments
    11.17 Xudong Haipu Pharmaceutical
        11.17.1 Xudong Haipu Pharmaceutical Company Details
        11.17.2 Xudong Haipu Pharmaceutical Business Overview
        11.17.3 Xudong Haipu Pharmaceutical Heart Failure Treatment Introduction
        11.17.4 Xudong Haipu Pharmaceutical Revenue in Heart Failure Treatment Business (2017-2022)
        11.17.5 Xudong Haipu Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables Table 1. Global Heart Failure Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Drug Treatment Table 3. Key Players of Surgical Treatment Table 4. Global Heart Failure Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Heart Failure Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Heart Failure Treatment Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Heart Failure Treatment Market Share by Region (2017-2022) Table 8. Global Heart Failure Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Heart Failure Treatment Market Share by Region (2023-2028) Table 10. Heart Failure Treatment Market Trends Table 11. Heart Failure Treatment Market Drivers Table 12. Heart Failure Treatment Market Challenges Table 13. Heart Failure Treatment Market Restraints Table 14. Global Heart Failure Treatment Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Heart Failure Treatment Revenue Share by Players (2017-2022) Table 16. Global Top Heart Failure Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Treatment as of 2021) Table 17. Ranking of Global Top Heart Failure Treatment Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Heart Failure Treatment Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Heart Failure Treatment Product Solution and Service Table 21. Date of Enter into Heart Failure Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Heart Failure Treatment Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Heart Failure Treatment Revenue Market Share by Type (2017-2022) Table 25. Global Heart Failure Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Heart Failure Treatment Revenue Market Share by Type (2023-2028) Table 27. Global Heart Failure Treatment Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Heart Failure Treatment Revenue Share by Application (2017-2022) Table 29. Global Heart Failure Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Heart Failure Treatment Revenue Share by Application (2023-2028) Table 31. North America Heart Failure Treatment Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Heart Failure Treatment Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Heart Failure Treatment Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Heart Failure Treatment Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Heart Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Heart Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Heart Failure Treatment Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Heart Failure Treatment Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Heart Failure Treatment Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Heart Failure Treatment Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Heart Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Heart Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Heart Failure Treatment Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Heart Failure Treatment Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Heart Failure Treatment Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Heart Failure Treatment Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Heart Failure Treatment Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Heart Failure Treatment Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Heart Failure Treatment Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Heart Failure Treatment Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Heart Failure Treatment Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Heart Failure Treatment Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Heart Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Heart Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Heart Failure Treatment Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Heart Failure Treatment Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Heart Failure Treatment Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Heart Failure Treatment Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Heart Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Heart Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 61. Pfizer Company Details Table 62. Pfizer Business Overview Table 63. Pfizer Heart Failure Treatment Product Table 64. Pfizer Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 65. Pfizer Recent Developments Table 66. Novartis Company Details Table 67. Novartis Business Overview Table 68. Novartis Heart Failure Treatment Product Table 69. Novartis Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 70. Novartis Recent Developments Table 71. Merck Company Details Table 72. Merck Business Overview Table 73. Merck Heart Failure Treatment Product Table 74. Merck Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 75. Merck Recent Developments Table 76. Sanofi Company Details Table 77. Sanofi Business Overview Table 78. Sanofi Heart Failure Treatment Product Table 79. Sanofi Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 80. Sanofi Recent Developments Table 81. Johnson & Johnson Company Details Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Heart Failure Treatment Product Table 84. Johnson & Johnson Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 85. Johnson & Johnson Recent Developments Table 86. AstraZeneca Company Details Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Heart Failure Treatment Product Table 89. AstraZeneca Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 90. AstraZeneca Recent Developments Table 91. GlaxoSmithKline Company Details Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Heart Failure Treatment Product Table 94. GlaxoSmithKline Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 95. GlaxoSmithKline Recent Developments Table 96. Amgen Company Details Table 97. Amgen Business Overview Table 98. Amgen Heart Failure Treatment Product Table 99. Amgen Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 100. Amgen Recent Developments Table 101. Bayer Company Details Table 102. Bayer Business Overview Table 103. Bayer Heart Failure Treatment Product Table 104. Bayer Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 105. Bayer Recent Developments Table 106. BMS Company Details Table 107. BMS Business Overview Table 108. BMS Heart Failure Treatment Product Table 109. BMS Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 110. BMS Recent Developments Table 111. Cardiorentis Company Details Table 112. Cardiorentis Business Overview Table 113. Cardiorentis Heart Failure Treatment Product Table 114. Cardiorentis Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 115. Cardiorentis Recent Developments Table 116. Cytokinetics Company Details Table 117. Cytokinetics Business Overview Table 118. Cytokinetics Heart Failure Treatment Product Table 119. Cytokinetics Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 120. Cytokinetics Recent Developments Table 121. Ono Pharmaceuticals Company Details Table 122. Ono Pharmaceuticals Business Overview Table 123. Ono Pharmaceuticals Heart Failure Treatment Product Table 124. Ono Pharmaceuticals Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 125. Ono Pharmaceuticals Recent Developments Table 126. Mylan Company Details Table 127. Mylan Business Overview Table 128. Mylan Heart Failure Treatment Product Table 129. Mylan Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 130. Mylan Recent Developments Table 131. NCPC Company Details Table 132. NCPC Business Overview Table 133. NCPC Heart Failure Treatment Product Table 134. NCPC Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 135. NCPC Recent Developments Table 136. Xinhua Group Company Details Table 137. Xinhua Group Business Overview Table 138. Xinhua Group Heart Failure Treatment Product Table 139. Xinhua Group Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 140. Xinhua Group Recent Developments Table 141. Xudong Haipu Pharmaceutical Company Details Table 142. Xudong Haipu Pharmaceutical Business Overview Table 143. Xudong Haipu Pharmaceutical Heart Failure Treatment Product Table 144. Xudong Haipu Pharmaceutical Revenue in Heart Failure Treatment Business (2017-2022) & (US$ Million) Table 145. Xudong Haipu Pharmaceutical Recent Developments Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. Global Heart Failure Treatment Market Share by Type: 2021 VS 2028 Figure 2. Drug Treatment Features Figure 3. Surgical Treatment Features Figure 4. Global Heart Failure Treatment Market Share by Application: 2021 VS 2028 Figure 5. Acute Heart Failure Case Studies Figure 6. Chronic Heart Failure Case Studies Figure 7. Heart Failure Treatment Report Years Considered Figure 8. Global Heart Failure Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global Heart Failure Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Heart Failure Treatment Market Share by Region: 2021 VS 2028 Figure 11. Global Heart Failure Treatment Market Share by Players in 2021 Figure 12. Global Top Heart Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Treatment as of 2021) Figure 13. The Top 10 and 5 Players Market Share by Heart Failure Treatment Revenue in 2021 Figure 14. North America Heart Failure Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America Heart Failure Treatment Market Size Market Share by Type (2017-2028) Figure 16. North America Heart Failure Treatment Market Size Market Share by Application (2017-2028) Figure 17. North America Heart Failure Treatment Market Size Share by Country (2017-2028) Figure 18. United States Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Heart Failure Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe Heart Failure Treatment Market Size Market Share by Type (2017-2028) Figure 22. Europe Heart Failure Treatment Market Size Market Share by Application (2017-2028) Figure 23. Europe Heart Failure Treatment Market Size Share by Country (2017-2028) Figure 24. Germany Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Heart Failure Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific Heart Failure Treatment Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific Heart Failure Treatment Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific Heart Failure Treatment Market Size Share by Region (2017-2028) Figure 34. China Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America Heart Failure Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America Heart Failure Treatment Market Size Market Share by Type (2017-2028) Figure 42. Latin America Heart Failure Treatment Market Size Market Share by Application (2017-2028) Figure 43. Latin America Heart Failure Treatment Market Size Share by Country (2017-2028) Figure 44. Mexico Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Heart Failure Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa Heart Failure Treatment Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa Heart Failure Treatment Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa Heart Failure Treatment Market Size Share by Country (2017-2028) Figure 50. Turkey Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE Heart Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Pfizer Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 54. Novartis Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 55. Merck Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 56. Sanofi Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 57. Johnson & Johnson Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 58. AstraZeneca Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 59. GlaxoSmithKline Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 60. Amgen Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 61. Bayer Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 62. BMS Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 63. Cardiorentis Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 64. Cytokinetics Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 65. Ono Pharmaceuticals Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 66. Mylan Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 67. NCPC Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 68. Xinhua Group Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 69. Xudong Haipu Pharmaceutical Revenue Growth Rate in Heart Failure Treatment Business (2017-2022) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global Cancer Immunotherapy Market to Grow at a (CAGR) of 13.9% during the Forecast Period 2022-2030

18-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Cancer Immunotherapy Market is projected to reach USD 275.5 billion by 2030. Moreover, increasing day-by-day incidence of cancer, increasing awareness about early diagnosis, the effectiveness of thera ...

Global In-Vehicle Infotainment Market to Grow at a (CAGR) of 9.8% during the Forecast Period 2022-2030

17-Nov-2022 | Automobile

As specified in our exclusive report, the global  In-Vehicle Infotainment Market is projected to reach USD 42.25 billion by 2030. In-vehicle infotainment systems provide entertainment and information services to the driver and passengers throughou ...

Global Blockchain in Healthcare Market to Grow at a (CAGR) of 59% during the Forecast Period 2022-2030

16-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global Blockchain in Healthcare Market is projected to reach USD 119 billion by 2030. The growing need for curbing these issues along with the increasing incidence of information leaks and data breaches has be ...

Global In Vitro Fertilization Market to Grow at a (CAGR) of 5.7% during the Forecast Period 2022-2030

14-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global In-Vitro Fertilization Market is projected to reach USD 32 billion by 2030. In-vitro fertilization involves some risks such as genetic disease transfer during the pr ...

Global Microfluidics Market to Grow at a (CAGR) of 15.8% during the Forecast Period 2022-2030

11-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Microfluidics Market is projected to reach USD 61 billion by 2030. The growth in demand for point-of-care (POC) devices is expected to majorly drive the market size in the coming years. Simultaneously demand ...

More News...